RecruitingNot ApplicableNCT06830577

Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Procedure

Efficacy of Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Procedure: A Randomized Controlled Study


Sponsor

Ain Shams University

Enrollment

129 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

in this study we are going to evaluate the efficacy of intra-ureteric aminophylline instillation in facilitating ureteric access sheath placement prior to flexible ureteroscopy in reducing ureteric injury rates.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Upper ureteric stones or renal stones \< 2 cm

Exclusion Criteria7

  • Ureteric strictures.
  • anatomic renal disorders
  • functional renal disorders
  • Urinary tract infection.
  • Coagulopathy and uncorrected bleeding disorders.
  • Prior DJ stenting
  • any contraindication for aminophylline use: (hypersensitivity to theophylline, ethylenediamine, or any component of the drug formulation, pregnancy or lactation, active peptic ulcer, presence of cardiologic diseases, presence of neurologic diseases, presence of renal impairment and presence of hepatic dysfunction)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGUsage of Aminophylline prior to ureteric dilatation in Flexible uretroscopy

Intraureteric aminophylline installation prior to ureteric dilatation

DEVICESequential teflon dilator usage prior to ureteric access sheath placement in flexible uretroscopy

traditional ureteral dilators will be used. We will start by ureteral dilator 6 fr and gradually increase the size up to 12 Fr

OTHERAminophylline instillation and Ureteral dilators together

Aminophylline will be instilled as in group (A) then followed by traditional ureteral dilatation as in group (B) prior to placing the ureteric access sheath


Locations(1)

Ain Shams University Hospitals

Cairo, Abassia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06830577


Related Trials